TrialDiabetologia2023

Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.

What the trial testedrandomised · 364 people · 2023

Randomised comparison

−1.47kg−2.58 to −0.35

As reported

difference −1.47 kg, 95% CI −2.58 to −0.35

the abstract, start to end

… the mean difference in weight was -1.47 kg (95% CI -2.58, -0.35).

← favours treatmentfavours comparator →

could be chance

Body weight & composition

−1.47−2.58 to −0.35

MetforminBody weight & composition

Metformin × body weight & compositionhelps?mixed

unlikelylikely

0.500.50 without it

← favours treatmentfavours comparator →

this papermore certainless certain

1 / 5

2023

2024

2025

2026

this paperpooled itcites it